Cell and Gene Logistics

  1. Breaking Down Shipping 11/13/2023

    Here, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich talk about whether temperature monitoring devices are really truly necessary when using a shipper that has been tested and validated to hold a specific temperature range for a specified period, and more.

  2. Inventory Management, Staff Training, And Timeline Optimization 11/13/2023

    In this segment, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich explain the improvements that can be made in each of the following: inventory management, staff training, and timeline.

  3. Regulatory Considerations For An Optimized Cold Chain 11/13/2023

    Here, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich detail some of the cold chain for cell therapies is beholden to regulatory requirements.

  4. Risk Mitigation Strategies 11/13/2023

    In this segment, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich explain some of the key risk management mitigation issues regarding managing temperature before, during, and after transit.

  5. Overcoming Cryopreservation Challenges 11/13/2023

    In this segment, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich share how they are tackling some of the biggest issues in cryopreservation as well as best practices given the complex structure of freezing and thawing systems.

  6. An Inside Look At Umoja Biopharma And Bristol Myers Squibb's Cold Chains 11/13/2023

    Umoja's Co-Founder and CTO Ryan Crisman details The CLIMB and how an optimized cold chain is critical in the work being done there. Rookie Gleich, Global Head, Cell Therapy Logistics and Shipping Systems, BMS explains some of the cell therapy temperature standardization and why a wider temperature range may optimize the process.

  7. Optimizing Autologous Cell Therapy Clinical Trials 11/6/2023

    Delve into four articles regarding dissecting the critical resources, processes, and key stakeholders essential for the successful completion of an ACT clinical trial.

  8. Evaluation Criteria Of Freezer Systems For Bulk Pharmaceuticals 11/1/2023

    Review data and evidence that demonstrates the benefits of an integrated approach to achieving critical end-user goals such as scalability, efficiency, sustainability, and optimized process economics.

  9. Optimizing Your Cold Chain For Cell Therapies 10/31/2023

    Cell & Gene’s Chief Editor Erin Harris and expert panelists discuss practical ways to improve shipping systems, tracking, product monitoring, and more for both just-in-time delivery and cryogenic preservation.

  10. Stainless Steel, Lead Shielded USP 825 Compliant Biosafety Cabinets 10/31/2023

    The RADIOSAFE Laminar Flow Biosafety Cabinet provides a high degree of localized protection from particulate and aerosol hazards. The work area of the biological safety cabinet is continuously bathed with laminar flow ISO 5 HEPA-filtered air to protect the product from contamination while an inward airflow protects the user. Approximately 70% of the air from each cycle is recirculated through the supply HEPA filter while the remaining air is discharged from the biosafety cabinet through the exhaust HEPA filter. An optional thimble connection allows for external ducting of the exhaust air.

    The Class II Type A RADIOSAFE Series of Biosafety Cabinets meets all requirements for USP 825 compliance and is constructed from 100% Stainless Steel.